Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries
Lunedì 9 gennaio 2023
ca. 1 min. di lettura
Journal and Affiliations:
Journal for ImmunoTherapy of Cancer, =novembre 2022
Luis Castelo-Branco, Scientific and Medical Division, ESMO, Lugano
Tags:
COVID-19
cytotoxicity, immunologic
immunogenicity, vaccine
immunotherapy
vaccination
Authors:
Luis Castelo-Branco